The U.S. Food and Drug Administration is warning that glycerin is not contaminated with diethylene glycol.
Ads by Google
Nationwide announced the introduction of Nationwide Select, the first stand-alone generic drug plan geared specifically to small to mid-size businesses in Philadelphia.
Alpharma presented positive results of a pharmacokinetic study of its investigational abuse-deterrent, extended-release opioid at the 26th annual scientific meeting of the American Pain Society in Washington.
The U.S. Food and Drug Administration issued the "Critical Path Opportunities for Generic Drugs" report identifying many of the unanswered scientific questions that impede the development of generic versions of commonly used drugs.
FDA is cautioning U.S. consumers about dangers associated with buying prescription drugs over the Internet.
Consumers have broad access to pharmacy choices in urban, suburban, and rural areas, as an average of 21 pharmacies are located and compete near independent pharmacies throughout the United States.
Consumers Union is urging the Senate to approve strong prescription drug-safety provisions this week in a major Food and Drug Administration bill, and resist attempts to weaken the bill when it comes to triggering quick safety action or moderating mass advertising of a new drug when there are signs of danger.
The U.S. District Court for the District of Columbia issued a decision denying all requests for preliminary injunction related to Amlodipine Besylate Tablets and supporting FDA's position concerning Mylan's current status as the only approved ANDA for all strengths of this product.
Duramed Pharmaceuticals announced that the Company has received two U.S. Food and Drug Administration approvals related to its ENJUVIA (synthetic conjugated estrogens, B) product.
Indiana Governor has signed legislation allowing physicians to delegate prescriptive authority to physician assistants within the state.
Drugs that adjust dopamine levels in the brain greatly affect how people react to success and failure.
Patients are being put at serious risk of medication errors as a result of not understanding prescription drug labels.
HD-02 is novel drug candidate for the treatment of Huntington's disease (HD) with orphan drug designation in the U.S.
Many believe the FDA and pharmaceutical companies should bear the most responsibility for drug safety, but are skeptical that they can be trusted to do so.
FDA announced the entry of a Consent Decree of Permanent Injunction against PharmaFab Inc. to stop the illegal manufacture and distribution of prescription and over-the-counter drug products.
High workloads for pharmacists increase the potential for medication and prescription drug errors.
Licensed pharmacies are the only stores that may sell prescription medications; and licensed pharmacies may sell these medications only to customers who present a prescription from a licensed health care provider.
Adam Sachs speaks with frequent travelers-including Daily Show regular John Hodgman-who collect over-the- counter European medications like souvenirs.
FDA is alerting health care professionals and consumers to the availability of audio broadcasts that provide emerging drug safety information.
UCSF is launching a new study to evaluate treatments for addiction to prescription painkillers and has openings for patients to enroll.
The Board of Pharmacy has adopted new rules on the responsibility of pharmacists and pharmacies to fill valid prescriptions in Washington.
The Hong Kong Department of Health called on the public not to buy or use two brands of health products which were found to have contained western drug ingredient for treating impotence and may cause side effects.
The Department of Health has requested a pharmaceutical company, Novartis Hong Kong Limited, to suspend marketing and sale of Zelmac, a treatment for irritable bowel syndrome and chronic constipation.
The Food and Drug Administration approved Altabax (retapamulin ointment) for topical treatment of impetigo, a skin infection caused by bacteria.
FDA wants your feedback on FDA's Medication Guide program.
At an average cost of $8.4 million, drug repurposing has become an attractive option for pharmaceutical companies of all sizes to pursue.
The Maine Natural Health Company has launched two new lines of nutraceutical drug products designed for people of all ages and therapeutic needs.
Abbott and World Health Organization have agreed on a balanced approach to provide Kaletra, Aluvia capsules and tablets to more patients in the developing world, while supporting continued long-term biopharmaceutical research and development.